Navigation Links
Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
Date:5/18/2009

Ellman International launches next-generation aesthetic skin tightening technology

OCEANSIDE, N.Y., May 18 /PRNewswire/ -- Ellman International, Inc. announced today that the Food and Drug Administration (FDA) has granted clearance to Pelleve(TM), a skin tightening system for the non-ablative treatment of mild to moderate facial wrinkles and rhytids for skin phototypes I-IV. The clearance was granted based on clinical data demonstrating that a single treatment with the high frequency radiowave device can safely and effectively tighten and improve the appearance of skin on the face through six months.

"Today's FDA clearance of the Pelleve system represents a very exciting step in the introduction of next-generation high frequency radiowave technology to physicians and patients in the United States," said Rick Epstein, CEO of Ellman International, Inc. "Pelleve offers safe, non-invasive facial rejuvenation with no need for a local anesthetic and minimal discomfort -- a significant evolution from previous-generation technologies in this class."

Pelleve uses the advanced radiowave technology of the Ellman International Surgitron(R) Dual RF(TM) S5 and a proprietary Pelleve handpiece to precisely deliver energy through the skin to the dermal tissue beneath without damaging the epidermis. This gentle heating of the deeper dermal tissue induces collagen denaturization and contraction. As the dermal tissue recovers, new collagen synthesis occurs, which creates a tightening effect. The result is a noticeable improvement in skin quality and appearance with minimal side effects and healing time for patients.

In a clinical trial conducted to determine the effectiveness of the Pelleve system, 83 women and 10 men were given a single treatment with the Pelleve handpiece. The procedure was performed in an ambulatory (outpatient) setting with no need for skin cooling products or anesthesia and took an
'/>"/>

SOURCE Ellman International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
2. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
3. NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device
4. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
5. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
6. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
7. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
8. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
9. Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study
10. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
11. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...K, Nov. 20 Medco Health ...g to a transformation in American healthcare throu...ready delivering higher quality clinical care and ...aking medicine smarter for the benefit of patients...ed how the elements in its strategy enable "Smarte...
(Date:11/20/2009)... YORK, Nov. 20 Reportlinker.com an...able in its catalogue. ,, Pipettes & Pipet.../www.reportlinker.com/p0164373/Pipettes--Pipettors...ewswire&utm_medium=pr&utm_campaign=prnewsw...an integral part of any research laboratory. Large...
(Date:11/20/2009)... YORK, Nov. 20 Reportlinker.com an...able in its catalogue. ,, Medical Adhesives an...w.reportlinker.com/p0164242/Medical-Adhesives-and-...wswire&utm_medium=pr&utm_campaign=prnewswi...ts is gaining preeminence in medical devices and e...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Almost Family to Present at Two Upcoming Conferences 47674 1Almost Family to Present at Two Upcoming Conferences 47674 2Seventy three scientists elected to the American Academy of Microbiology 8700 1Seventy three scientists elected to the American Academy of Microbiology 8700 2Seventy three scientists elected to the American Academy of Microbiology 8700 3Seventy three scientists elected to the American Academy of Microbiology 8700 4Leading Patient Advocacy Organizations United on Health Care Reform Principles 47671 1Leading Patient Advocacy Organizations United on Health Care Reform Principles 47671 2Leading Patient Advocacy Organizations United on Health Care Reform Principles 47671 3
... from Phase III Intergroupe Francophone du Myelome...ss., July 02, 2007 /PRNewswire-FirstCall/ --,Mille...w data were,presented on the comparative Phase III... in newly diagnosed multiple myeloma (MM),patients...ntation,(SCT), the VELCADE based therapy produced ...
...pdate to Timeline for Second Pivotal Phase 3 Trial...ll/ -- Advanced Life,Sciences Holdings, Inc. , tod...cacy data from Trial CL-06, the first of two,pivot...safety and,effectiveness of cethromycin, a novel o...ty acquired pneumonia (CAP). The Company,also prov...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
(Date:11/20/2009)...nadian study finds more severe cases than with sea...y News) -- Canadian researchers are reporting that...evere cases of H1N1 flu than seasonal flu. , "A...ctor for admission with pandemic H1N1 influenza, p...amples," wrote Dr. Upton Allen and fellow research...
(Date:11/20/2009)... Longtime OB/GYN warns agai... by the U.S. Preventative Services Task Force. The... at the price of human lives. When is it wrong to ... new U.S. Preventative Services Task Force recomme...nals of Internal Medicine, has set off a firestorm...
(Date:11/20/2009)..., , SPRINGFIELD, Mo., Nov. 20 ...th Central Missouri regions will now have the opti...ment reached Tuesday between Missouri Consolidated...,, The Southwest and South Central Missouri reg..., Cedar, Christian, Dade, Dallas, Douglas, Greene,...
(Date:11/20/2009)..., , ,, LOS ANGELES, Nov. 20 /PRNewsw...ing Healthy African American Families, The Wall/La...bershop Health Outreach Program, and the Real Medi... of California calling on the company to reconside..., The letter to Blue Shield specifically calls f...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 Today...l retailer HSN announce the launch of a capsule gi...d HSN.com for the holiday season. This collection...en,s Research Hospital,s Thanks and Giving® ...ram which encourages consumers to "give thanks for...
Breaking Medicine News(10 mins):Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3
...Information,Management Association congratulates S...Human Services on the approval of Final Rules for ... will greatly improve America,s health,information...tion management profession is eager to help lead t...
...own professional athletes will receive honors at ...esented by Navistar to benefit the March of D...uary 9th, 5 - 9 p.m. at the Hilton Chicago, 720 S....ave made considerable contributions to their teams...
...ns who have been shortchanged , , CHICAGO, Jan.... with the Medical Society of the State of New York...s victory with the settlement agreement reached to...single health insurer in the U.S. , , (Logo: ht...
...stleblower Clients Help Government Recover $1.4 Bi...illy & Company Zyprexa(R) Marketing Case , , ... Six Whistleblowers , , PHILADELPHIA, Jan. 15 P...l marketing scheme for its prescription drug, Zypr...
...y announced today it has agreed to plead guilty to... in criminal and civil fines, penalties and damage...eblower lawsuits that the pharmaceutical giant def...ychotic, Zyprexa. The settlement is the largest ...
...se of the generosity of donors and their families ...ave been the toughest kid on the football field, b...tions of continuing that after he graduated high s...alked about it, his son,s aspirations seemed like ...
Other Medicine News:Health News:AHIMA Applauds HHS Approval of ICD-10 Final Rules 2Health News:Chicago's Sports Stars Honored at Annual Dinner Benefiting the March of Dimes 2Health News:AMA Claims Victory With Record Breaking Settlement in Case Against Insurer 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 2Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 3Health News:The Largest Pharma Fraud Whistleblower Case in U.S. History Totaling $1.4 Billion 4Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 2Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 3Health News:Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices 4Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 2Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 3Health News:Gift of Life Celebrates 35th Anniversary as National Leader in Organ Donation 4
Xenon Light Source
Portable Mini Halogen Light
Micro-Mini Fiber Optic Light - HLT150
Zeon Illuminator
Medicine Products: